Search
for
Sort by
Research 121–150 of 1000+
- 1338 Dermal Wnt/β-catenin activation tunably controls hair follicle initiation
- Scaly Papular Lesions
- Alopecia
- In vivo Study of the Effect of 5 and 10% Nebivolol Cream on Hair Growth in Mice Models
- Association of common medication with prostate-specific antigen level in 45-year-old German men: Results of the PROBASE trial
- Discovery of New Drug Therapies Based on the Study of Adverse Reactions
- New onset of alopecia in a young woman with end-stage renal disease
- Follicular Neutrophilic Inflammation (Hidradenitis Suppurativa)
- Elastogenesis Stimulation by Minoxidil or Nebivolol Reduces Premature Aging of the Aortic Wall in Diabetic Mice
- The Transcriptional Co-Activator cAMP Response Element-Binding Protein-Binding Protein Is Expressed in Prostate Cancer and Enhances Androgen- and Anti-Androgen-Induced Androgen Receptor Function
- What do we know about phytotherapy of benign prostatic hyperplasia?
- Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases
- Anticytokine therapy, particularly anti-IFN-γ, in Th1-mediated autoimmune diseases
- Dutasteride: A Review of its Use in the Management of Prostate Disorders
- Androgenic Alopecia: Cross-Talk Between Cell Signal Transduction Pathways
- Skin involvement in systemic lupus erythematosus: a review article
- Hair Loss and Androgen’s Role in the Era of COVID-19
- A Review on Nanoparticle Based Herbal Remedies for the Management of Alopecia
- 13. Wound Healing & Hair
- 4. Bullous/Mucous Membrane
- Long-Term Clinical Effects, Bioavailability, and Kinetics of Minoxidil in Relation to Renal Function
- Ottawa, Ontario, Canada, February 13–16, 2013
- Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society
- The Rotterdam Study: 2016 objectives and design update
- Drug Reactions Affecting Hair: Diagnosis
- A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia
- Telogen Effluvium: A Review
- Advanced nanocarrier- and microneedle-based transdermal drug delivery strategies for skin diseases treatment
- Telogen effluvium
- Cutaneous effects of the most commonly used antidepressant medication, the selective serotonin reuptake inhibitors